Brixton-Neural Ice:  Woman walking through snowy forest

Discover ReneuRxTM
Nerve-Selective Therapy

Learn More
Illustration of Coolio being injected into a knee joint

Our Goal, Long-Lasting Pain Control

With ReneuRx™ therapy, patients may benefit from 3 months or more of pain relief from a single treatment.

ReneuRx™ Therapy will be an Inflection Point in Pain Management

Developed at Massachusetts General Hospital

ReneuRx™ therapy was developed at Mass General Hospital and is backed by several years of academic research.

First In-Human Study in 2023

Pain management reaches an important milestone with the first clinical research study measuring safety and relief of knee pain using ReneuRx™ therapy.

Potential to treat both acute and chronic pain

ReneuRx™ therapy has the potential to transform how we manage pain and address a massive unmet clinical need.

Lead by Research

Our founders have an impressive track record of execution and deep research histories affiliated with world-class organizations.

Meet Brixton
Rox Anderson and Sameer Sabir, founders of Brixton with logos of  their affiliations